Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care
The Hospital to Home Study: A Pragmatic Trial to Optimize Transitions and Address Disparities in Asthma Care
Who can join
Ages 4 to 12 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. speak English or Spanish 2. are at least 18 years old 3. live in the District of Columbia, Maryland, or Virginia (DMV) 4. have a child aged 4-12 years who is hospitalized due to asthma exacerbation. Exclusion Criteria: 1. . Children ages 4-12 years with chronic medical condition (other than asthma) including but not limited to diabetes, sickle cell disease, heart disease, lung disease or neurological disorder 2. . Children ages 4-12 years involved in interventions with behavioral component and/or novel asthma therapeutics will be excluded given overlap with the current intervention 3. . Children ages 4-12 years in foster care 4. . Families not residing in the DMV 5. . Caregivers who do not speak English or Spanish
About the study
Caregiver-child dyads will be recruited during child's hospital admission for asthma exacerbation. Recruitment sites will be mainly Children's National Hospital Sheikh Zayed campus, as well as regional partners: Holy Cross Hospital, and Mary Washington Hospital. After enrollment, baseline data will be collected from caregiver. Caregiver-child dyads will be randomized (1:1 ratio) into the control arm or intervention arm. Control arm will receive the standard of care after hospital discharge. Intervention arm will receive the SOC plus an asthma navigator support after hospital discharge. Caregivers in both arms will complete data collection surveys (either in-person or via telehealth) at 3-,6-, 9-, and 12- month post enrollment.
What is being tested
- Hospital to Home Transition (H2H) (behavioral)
Sponsor: Kavita Parikh · Participants: 340 · Started: Jan 22, 2024
Contact the study team
- Kavita Parikh, MD MSHS · Phone: 2024766366
- Alicia Mathis · Phone: 2024764698
Official record on ClinicalTrials.gov — NCT05991115
Locations in the U.S.
| District of Columbia | Children's National Hospital, Washington D.C. |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.